JPRN-UMIN000048638已完成未知
Humoral and T-cell responses to a fourth dose of BNT162b2 and mRNA-1273 COVID-19 Vaccine in Patients with hematological diseases treated with rituximab or obinutuzumab: An observational study. - COVID-19 anti-CD20mAb 4th vaccine study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients deemed inappropriate for study participation by the principal investigator or study investigators 2) Patients who have received rituximab for non-hematologic diseases (granulomatosis polyangiitis, microscopic polyangiitis, refractory nephrotic syndrome) 3) Patients with a history of COVID-19 4) Patients with autoimmune diseases other than chronic idiopathic thrombocytopenic purpura (systemic lupus erythematosus, Sjogren's syndrome, dermatomyositis and polymyositis, mixed connective tissue disease, systemic scleroderma, rheumatoid arthritis, polymyalgia rheumatica, psoriatic arthritis, spondyloarthritis and related diseases, vasculitis syndrome, inflammatory bowel disease, and Guillain-Barre syndrome, multiple sclerosis, neuromyelitis optica). 5) Patients who are unable to communicate.
研究者
相似试验
已完成
不适用
Humoral and T-cell responses to a third dose of BNT162b2 and mRNA-1273 COVID-19 Vaccine in Patients with hematological diseases treated with rituximab or obinutuzumab: An observational study.Hematological diseasesJPRN-UMIN000046603Kobe City Medical Center General Hospital, Department of Hematology68
尚未招募
3 期
Immunogenicity and safety after vaccinated with BBIBP-CorV (COVID-19 vaccine) in Thai pregnant womePregnant womenCOVID-19SARS-CoV-2 vaccineVaccinePregnantBBIBP-CorVSinopharmTCTR20210923013Chulabhorn Hospital400
招募中
不适用
The comparison of Immune response to the 4th dose booster with mRNA-1273 COVID-19 vaccine in individuals who had received 2 doses of CoronaVac and booster with ChAdOx-1 or BNT162b2 COVID-19 vaccineBooster vaccination with mRNA 1273 COVID vaccine in individuals who had received 2 doses of CoronaVac and booster with BNT162b2 or ChAdOx-1 COVID vaccine.mRNA 1273 , booster, covid 19 vaccine, immunogenicityTCTR20220205002Thammasat University Hospital100
进行中（未招募）
不适用
Immune respons after TB-vaccinatioEUCTR2011-005653-31-NLMC, Department Infection Disease25
已完成
不适用
Immunological effects of BCG on vaccination with the yellow fever vaccine.Immune modulationmodulation of the immune system10002252NL-OMON40902niversitair Medisch Centrum Sint Radboud30